{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T22:26:46Z","timestamp":1793917606824,"version":"4.8.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T00:00:00Z","timestamp":1683763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T00:00:00Z","timestamp":1683763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81874017"],"award-info":[{"award-number":["81874017"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Osteoporos"],"DOI":"10.1007\/s11657-023-01261-7","type":"journal-article","created":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T13:45:28Z","timestamp":1683812728000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Efficacy and safety of odanacatib for osteoporosis treatment: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"18","author":[{"given":"Rongjin","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changshun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenhui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hefang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yayi","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,11]]},"reference":[{"key":"1261_CR1","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/jbmr.2072","volume":"29","author":"S Amin","year":"2014","unstructured":"Amin S, Achenbach SJ, Atkinson EJ, Khosla S, Melton LJ 3rd (2014) Trends in fracture incidence: a population-based study over 20 years. J Bone Miner Res 29:581\u2013589. https:\/\/doi.org\/10.1002\/jbmr.2072","journal-title":"J Bone Miner Res"},{"key":"1261_CR2","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1002\/jcsm.12757","volume":"12","author":"F Petermann-Rocha","year":"2021","unstructured":"Petermann-Rocha F, Ferguson LD, Gray SR, Rodr\u00edguez-G\u00f3mez I, Sattar N, Siebert S, Ho FK, Pell JP, Celis-Morales C (2021) Association of sarcopenia with incident osteoporosis: a prospective study of 168,682 UK Biobank participants. J Cachexia Sarcopenia Muscle 12:1179\u20131188. https:\/\/doi.org\/10.1002\/jcsm.12757","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"1261_CR3","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1093\/bmb\/ldaa005","volume":"133","author":"MA Clynes","year":"2020","unstructured":"Clynes MA, Harvey NC, Curtis EM, Fuggle NR, Dennison EM, Cooper C (2020) The epidemiology of osteoporosis. Br Med Bull 133:105\u2013117. https:\/\/doi.org\/10.1093\/bmb\/ldaa005","journal-title":"Br Med Bull"},{"key":"1261_CR4","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/S2213-8587(19)30348-1","volume":"7","author":"LA Statham","year":"2019","unstructured":"Statham LA, Aspray TJ (2019) Odanacatib: the best osteoporosis treatment we never had? Lancet Diabetes Endocrinol 7:888\u2013889. https:\/\/doi.org\/10.1016\/S2213-8587(19)30348-1","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1261_CR5","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/nrd.2016.207","volume":"15","author":"A Mullard","year":"2016","unstructured":"Mullard A (2016) Merck & Co. drops osteoporosis drug odanacatib. Nat Rev Drug Discov 15:669. https:\/\/doi.org\/10.1038\/nrd.2016.207","journal-title":"Nat Rev Drug Discov"},{"key":"1261_CR6","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00198-020-05701-9","volume":"32","author":"N Binkley","year":"2021","unstructured":"Binkley N, Orwoll E, Chapurlat R, Langdahl BL, Scott BB, Giezek H, Santora AC (2021) Randomized, controlled trial to assess the safety and efficacy of odanacatib in the treatment of men with osteoporosis. Osteoporos Int 32:173\u2013184. https:\/\/doi.org\/10.1007\/s00198-020-05701-9","journal-title":"Osteoporos Int"},{"key":"1261_CR7","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1210\/jc.2012-2972","volume":"98","author":"K Brixen","year":"2013","unstructured":"Brixen K, Chapurlat R, Cheung AM, Keaveny TM, Fuerst T, Engelke K, Recker R, Dardzinski B, Verbruggen N, Ather S, Rosenberg E, de Papp AE (2013) Bone density, turnover, and estimated strength in postmenopausal women treated with odanacatib: a randomized trial. J Clin Endocrinol Metab 98:571\u2013580. https:\/\/doi.org\/10.1210\/jc.2012-2972","journal-title":"J Clin Endocrinol Metab"},{"key":"1261_CR8","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1359\/jbmr.091035","volume":"25","author":"HG Bone","year":"2010","unstructured":"Bone HG, McClung MR, Roux C, Recker RR, Eisman JA, Verbruggen N, Hustad CM, DaSilva C, Santora AC, Ince BA (2010) Odanacatib, a cathepsin-K inhibitor for osteoporosis: a two-year study in postmenopausal women with low bone density. J Bone Miner Res 25:937\u2013947. https:\/\/doi.org\/10.1359\/jbmr.091035","journal-title":"J Bone Miner Res"},{"key":"1261_CR9","doi-asserted-by":"publisher","first-page":"4727","DOI":"10.1210\/jc.2013-2020","volume":"98","author":"S Bonnick","year":"2013","unstructured":"Bonnick S, De Villiers T, Odio A, Palacios S, Chapurlat R, DaSilva C, Scott BB, De Le BaillyTilleghem C, Leung AT, Gurner D (2013) Effects of odanacatib on BMD and safety in the treatment of osteoporosis in postmenopausal women previously treated with alendronate: a randomized placebo-controlled trial. J Clin Endocrinol Metab 98:4727\u20134735. https:\/\/doi.org\/10.1210\/jc.2013-2020","journal-title":"J Clin Endocrinol Metab"},{"key":"1261_CR10","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/jbmr.212","volume":"26","author":"JA Eisman","year":"2011","unstructured":"Eisman JA, Bone HG, Hosking DJ, McClung MR, Reid IR, Rizzoli R, Resch H, Verbruggen N, Hustad CM, DaSilva C, Petrovic R, Santora AC, Ince BA, Lombardi A (2011) Odanacatib in the treatment of postmenopausal women with low bone mineral density: three-year continued therapy and resolution of effect. J Bone Miner Res 26:242\u2013251. https:\/\/doi.org\/10.1002\/jbmr.212","journal-title":"J Bone Miner Res"},{"key":"1261_CR11","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/jbmr.2292","volume":"30","author":"K Engelke","year":"2015","unstructured":"Engelke K, Fuerst T, Dardzinski B, Kornak J, Ather S, Genant HK, de Papp A (2015) Odanacatib treatment affects trabecular and cortical bone in the femur of postmenopausal women: results of a two-year placebo-controlled trial. J Bone Miner Res 30:30\u201338. https:\/\/doi.org\/10.1002\/jbmr.2292","journal-title":"J Bone Miner Res"},{"key":"1261_CR12","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1002\/jbmr.1695","volume":"27","author":"B Langdahl","year":"2012","unstructured":"Langdahl B, Binkley N, Bone H, Gilchrist N, Resch H, Rodriguez Portales J, Denker A, Lombardi A, De Le BaillyTilleghem C, Dasilva C, Rosenberg E, Leung A (2012) Odanacatib in the treatment of postmenopausal women with low bone mineral density: five years of continued therapy in a phase 2 study. J Bone Miner Res 27:2251\u20132258. https:\/\/doi.org\/10.1002\/jbmr.1695","journal-title":"J Bone Miner Res"},{"key":"1261_CR13","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/S2213-8587(19)30346-8","volume":"7","author":"MR McClung","year":"2019","unstructured":"McClung MR, O\u2019Donoghue ML, Papapoulos SE, Bone H, Langdahl B, Saag KG, Reid IR, Kiel DP, Cavallari I, Bonaca MP, Wiviott SD, de Villiers T, Ling X, Lippuner K, Nakamura T, Reginster JY, Rodriguez-Portales JA, Roux C, Zanchetta J, Zerbini CAF, Park JG, Im K, Cange A, Grip LT, Heyden N, DaSilva C, Cohn D, Massaad R, Scott BB, Verbruggen N, Gurner D, Miller DL, Blair ML, Polis AB, Stoch SA, Santora A, Lombardi A, Leung AT, Kaufman KD, Sabatine MS, investigators L (2019) Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT extension study. Lancet Diabetes Endocrinol 7:899\u2013911. https:\/\/doi.org\/10.1016\/S2213-8587(19)30346-8","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1261_CR14","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s00198-013-2398-2","volume":"25","author":"T Nakamura","year":"2014","unstructured":"Nakamura T, Shiraki M, Fukunaga M, Tomomitsu T, Santora AC, Tsai R, Fujimoto G, Nakagomi M, Tsubouchi H, Rosenberg E, Uchida S (2014) Effect of the cathepsin K inhibitor odanacatib administered once weekly on bone mineral density in Japanese patients with osteoporosis\u2014a double-blind, randomized, dose-finding study. Osteoporos Int 25:367\u2013376. https:\/\/doi.org\/10.1007\/s00198-013-2398-2","journal-title":"Osteoporos Int"},{"key":"1261_CR15","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1002\/jbmr.3994","volume":"35","author":"R Recker","year":"2020","unstructured":"Recker R, Dempster D, Langdahl B, Giezek H, Clark S, Ellis G, de Villiers T, Valter I, Zerbini CA, Cohn D, Santora A, Duong LT (2020) Effects of odanacatib on bone structure and quality in postmenopausal women with osteoporosis: 5-year data from the phase 3 long-term odanacatib fracture trial (LOFT) and its extension. J Bone Miner Res 35:1289\u20131299. https:\/\/doi.org\/10.1002\/jbmr.3994","journal-title":"J Bone Miner Res"},{"key":"1261_CR16","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1007\/s00774-014-0609-3","volume":"33","author":"S Feng","year":"2015","unstructured":"Feng S, Luo Z, Liu D (2015) Efficacy and safety of odanacatib treatment for patients with osteoporosis: a meta-analysis. J Bone Miner Metab 33:448\u2013454. https:\/\/doi.org\/10.1007\/s00774-014-0609-3","journal-title":"J Bone Miner Metab"},{"key":"1261_CR17","doi-asserted-by":"publisher","first-page":"3070","DOI":"10.1210\/jc.2014-1162","volume":"99","author":"O Gajic-Veljanoski","year":"2014","unstructured":"Gajic-Veljanoski O, Tomlinson G, Srighanthan J, Adachi JD, Josse R, Brown JP, Cheung AM (2014) Effect of odanacatib on BMD and fractures: estimates from Bayesian univariate and bivariate meta-analyses. J Clin Endocrinol Metab 99:3070\u20133079. https:\/\/doi.org\/10.1210\/jc.2014-1162","journal-title":"J Clin Endocrinol Metab"},{"key":"1261_CR18","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1210\/er.2015-1114","volume":"38","author":"MT Drake","year":"2017","unstructured":"Drake MT, Clarke BL, Oursler MJ, Khosla S (2017) Cathepsin K inhibitors for osteoporosis: biology, potential clinical utility, and lessons learned. Endocr Rev 38:325\u2013350. https:\/\/doi.org\/10.1210\/er.2015-1114","journal-title":"Endocr Rev"},{"key":"1261_CR19","first-page":"499","volume":"52","author":"JM Halleen","year":"2006","unstructured":"Halleen JM, Tiitinen SL, Ylipahkala H, Fagerlund KM, V\u00e4\u00e4n\u00e4nen HK (2006) Tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of bone resorption. Clin Lab 52:499\u2013509","journal-title":"Clin Lab"},{"key":"1261_CR20","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jaad.2008.03.009","volume":"59","author":"A Peroni","year":"2008","unstructured":"Peroni A, Zini A, Braga V, Colato C, Adami S, Girolomoni G (2008) Drug-induced morphea: report of a case induced by Balicatib and review of the literature. J Am Acad Dermatol 59:125\u2013129. https:\/\/doi.org\/10.1016\/j.jaad.2008.03.009","journal-title":"J Am Acad Dermatol"}],"container-title":["Archives of Osteoporosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-023-01261-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11657-023-01261-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-023-01261-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T08:29:34Z","timestamp":1704356974000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11657-023-01261-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,11]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1261"],"URL":"https:\/\/doi.org\/10.1007\/s11657-023-01261-7","relation":{},"ISSN":["1862-3514"],"issn-type":[{"value":"1862-3514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,11]]},"assertion":[{"value":"9 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"67"}}